Nuo Therapeutics Inc

OTCQB:AURXUnited States

Nuo Therapeutics, Inc. is a commercial stage medical device company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's product, Aurix, is a biodynamic hematogel that uses a patient's own platelets and plasma as a catalyst for healing. Its commercial offering consists of point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. This offering is known as Aurix or the Aurix System. The Aurix System produces a platelet rich plasma (PRP) gel at the point of care using the patient's own platelets and plasma sourced from a small draw of peripheral blood. Aurix comprises a natural, endogenous complement of protein and non-protein signal molecules that contribute to effective healing.

Contact Information

Headquarters

8285 EL RIO, SUITE 150HOUSTON, TX, United States 77054

Phone

832-236-9060

Fax

240-499-2690

Executives

Acting Chief Executive Officer, Acting Chief Financial Officer, Director

David Jorden

Chief Operating Officer, Chief Scientific Officer

Peter Clausen

Independent Director

Paul Mintz

Independent Director

Scott Pittman

Independent Director

C. Eric Winzer